Department of Gastroenterology, Fukuoka University Chikushi Hospital, 1-1-1 Zokumyoin, Chikushino, Fukuoka, 818-0067, Japan.
Inflammatory Bowel Disease Center, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
J Gastroenterol. 2019 Jan;54(1):42-52. doi: 10.1007/s00535-018-1482-y. Epub 2018 Jun 9.
In this study, survival and cause of death were investigated in patients with Crohn's disease (CD) at a tertiary referral center.
A database was created based on the medical records of 1108 CD patients who had a history of visiting our hospital to investigate background characteristics, cumulative survival rates from diagnosis, causes of death, and the standardized mortality ratio (SMR) for each cause of death. A follow-up questionnaire survey of patients followed up inadequately was also conducted. The cumulative survival rate from diagnosis was determined using the life table method and compared with that of a sex- and age-matched population model from the year 2000.
The study included 1108 patients whose mean age at diagnosis was 25.6 ± 10.8 years. The mean duration of follow-up was 14.6 ± 9.4 years, and there were 52 deaths. The cumulative survival rate was significantly lower 25 years after the diagnosis of CD (91.7%) than in the standard population model (95.7%). SMRs for both all causes [3.5; 95% confidence interval (CI): 2.7-4.6] and CD-specific causes (36.7; 95% CI 26.1-51.6) were high. Among the CD-specific causes, SMRs were especially high for small intestine and colorectal cancers, gastrointestinal diseases including intestinal failure (IF), perioperative complications, and amyloidosis.
The SMRs for both all causes and CD-specific causes were high in CD patients. CD-specific causes including intestinal cancer, IF, perioperative complications, and amyloidosis showed especially high SMRs.
本研究旨在某三级转诊中心调查克罗恩病(CD)患者的生存情况和死亡原因。
我们创建了一个数据库,其中包含 1108 例曾在我院就诊的 CD 患者的病历资料,以调查其背景特征、从诊断起的累积生存率、死亡原因以及每种死因的标准化死亡率(SMR)。我们还对随访不充分的患者进行了随访问卷调查。使用寿命表法确定从诊断起的累积生存率,并与 2000 年的性别和年龄匹配人群模型进行比较。
本研究共纳入 1108 例患者,诊断时的平均年龄为 25.6±10.8 岁。平均随访时间为 14.6±9.4 年,共有 52 例死亡。CD 诊断后 25 年的累积生存率明显低于标准人群模型(91.7% vs. 95.7%)。所有原因的 SMR[3.5;95%可信区间(CI):2.7-4.6]和 CD 特异性原因的 SMR(36.7;95% CI 26.1-51.6)均较高。在 CD 特异性原因中,小肠和结直肠癌、包括肠衰竭(IF)在内的胃肠道疾病、围手术期并发症和淀粉样变性的 SMR 尤其高。
CD 患者的所有原因和 CD 特异性原因的 SMR 均较高。CD 特异性原因,包括肠道癌症、IF、围手术期并发症和淀粉样变性,显示出较高的 SMR。